Concepedia

Colin J. Meyer

CJ

Statistics

Publications

54

Citations

6.4K

H-Index

39

Active since

1994

Affiliations

Reata Pharmaceuticals (United States)(Current)

Stanford University

Renal Associates P. A.

The University of Texas Southwestern Medical Center

University of Chicago

Colin J. Meyer is an author at Reata Pharmaceuticals (United States) specializing in medicine, pharmacology, and oxidative stress.

Top concepts

Publications per year

1994–2023

54

Publications

54

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

Dick de Zeeuw, Tadao Akizawa, Paul Audhya et al. · New England Journal of Medicine · 2013 · 969 citations · Full text

Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

Pablo E. Pérgola, Philip Raskin, Robert D. Toto et al. · New England Journal of Medicine · 2011 · 868 citations · Full text

Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress–Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo

Yi Tan, Tomonaga Ichikawa, Jinqing Li et al. · Diabetes · 2011 · 388 citations · Full text

Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer

Srinivas Nagaraj, Je-In Youn, Hannah Weber et al. · Clinical Cancer Research · 2010 · 275 citations · Full text

Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (<scp>MOXIe</scp> Study)

David R. Lynch, Melanie Chin, Martin B. Delatycki et al. · Annals of Neurology · 2020 · 273 citations · Full text

1–5 of 54